SCHEMBL27680637

SCHEMBL27680637

FC(F)(F)Oc1ccccc1Br.O=S(=O)(Cl)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ SLC22A12 Q96S37 3/20 0.38
▸ PTGES2 Q9H7Z7 1/20 0.38
▸ ALPL P05186 3/20 0.37
▸ GAA P10253 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ RXRG P48443 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KCNK3 O14649 2/20 0.35
▸ KCNK9 Q9NPC2 2/20 0.35
▸ CA4 P22748 1/20 0.35
▸ CA6 P23280 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL615592 0.88 HTR7 (0.38) CA1CA2CA5ACA9GAA
SCHEMBL29471353 0.88 HTR7 (0.38) CA1CA2CA5ACA9GAA
SCHEMBL28015639 0.86 HTR7 (0.37) CA1CA2CA5ACA9GAA
SCHEMBL28313676 0.79 EPHX2 (0.40) SLC22A12PTGES2ALPLGAARXRA
SCHEMBL28312858 0.79 SLC22A12 (0.45) SLC22A12RORC
SCHEMBL28777064 0.78 SLC22A12 (0.38) SLC22A12PTGES2ALPLGAARXRA
SCHEMBL9804688 0.76 HTR7 (0.36) CA1CA2CA5ACA9L3MBTL1
SCHEMBL122293 0.76 SLC22A12 (0.48) SLC22A12PTGES2ALPLSLC40A1RORC
SCHEMBL29520001 0.76 SLC22A12 (0.48) SLC22A12PTGES2ALPLSLC40A1RORC
SCHEMBL27418721 0.75 ALDH1A1 (0.47) SLC22A12PTGES2ALPLGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105102449-A Antiviral compounds HOFFMANN LA ROCHE 2015-11-25 — — CN disclosed
CN-101421234-A Is suitable for treating p-hydroxytryptamine 5HT6Heterocyclic aryl sulfones of receptor-modulated responsive disorders ABBOTT GMBH (DE) 2009-04-29 — — CN disclosed
CN-101068801-A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for the treatment of disorders which respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO KG (DE) 2007-11-07 — — CN disclosed
CN-101039904-A Is suitable for treating dopamine D3Heterocyclic compounds for receptor-modulated responsive disorders ABBOTT GMBH & CO KG (DE) 2007-09-19 — — CN disclosed
Send feedback